Skip to main content
Premium Trial:

Request an Annual Quote

BC Proteomics Network Receives $1.6M from Michael Smith Foundation for Health Research

NEW YORK (GenomeWeb News) – The BC Proteomics Network said yesterday that it has received funding from the Michael Smith Foundation for Health Research totaling $1.6 million over five years.

The money is a renewal of a previous five-year award from MSFHR, and is intended to help the network expand its proteomics-based offerings to clinical practices and health systems in British Columbia. It will also help the organization move toward financial sustainability.

"We thank the MSFHR for this new funding and are excited about the opportunity to grow proteomics resources in the province with the expectation of an improvement in healthcare practices over the next five years," Christoph Borchers, the network's scientific director, said in a statement.

Established in 2007, the BC Proteomics Network works to support research across the province and unify its proteomics resources.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.